AI and Predictive Analytics Revolutionize Clinical Trial Recruitment and Monitoring
Artificial intelligence (AI) and predictive analytics are significantly transforming the landscape of clinical trials. By utilizing large datasets such as electronic health records, genomic information, and demographic profiles, these technologies enhance patient recruitment, optimize site selection, and predict dropout rates. AI-driven adaptive trial designs allow for protocol modifications based on interim data, improving trial efficiency and patient safety. Additionally, predictive analytics facilitates real-time monitoring of participants and early detection of adverse events. Despite these advancements, ethical considerations, data privacy, and regulatory acceptance remain crucial for widespread adoption.